Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Trevena Inc (TRVN)

Trevena Inc (TRVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 98,201
  • Shares Outstanding, K 164,518
  • Annual Sales, $ 3,070 K
  • Annual Income, $ -29,370 K
  • 60-Month Beta 2.17
  • Price/Sales 151.49
  • Price/Cash Flow N/A
  • Price/Book 1.25
Trade TRVN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.31
  • Most Recent Earnings N/A on 11/15/21
  • Next Earnings Date 03/08/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 278.81% ( -255.85%)
  • Historical Volatility 67.65%
  • IV Percentile 97%
  • IV Rank 25.16%
  • IV High 979.67% on 01/07/22
  • IV Low 43.16% on 10/18/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 646
  • Volume Avg (30-Day) 378
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 19,017
  • Open Int (30-Day) 17,333

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5600 +6.59%
on 12/30/21
0.7294 -18.17%
on 12/17/21
-0.0776 (-11.50%)
since 12/14/21
3-Month
0.5600 +6.59%
on 12/30/21
1.2000 -50.26%
on 10/15/21
-0.5631 (-48.54%)
since 10/14/21
52-Week
0.5600 +6.59%
on 12/30/21
3.1000 -80.75%
on 02/10/21
-1.5831 (-72.62%)
since 01/14/21

Most Recent Stories

More News
Trevena to Participate in the Upcoming January Conferences

CHESTERBROOK, Pa., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and...

TRVN : 0.5969 (+1.26%)
Trevena (TRVN) to Begin Clinical Study on Pain Candidate

Trevena (TRVN) advances TRV045 into clinical development as a potential treatment for diabetic neuropathic pain. Enrollment in the study is expected to begin in the first quarter of 2022.

SRPT : 71.10 (-1.78%)
TRVN : 0.5969 (+1.26%)
VTVT : 0.8789 (+2.44%)
EDIT : 22.10 (+1.05%)
Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain

3-part randomized, double-blind, placebo-controlled Phase 1 study will evaluate TRV045 safety, tolerability, and PK in healthy volunteers Enrollment...

TRVN : 0.5969 (+1.26%)
Trevena (TRVN) Reports Q3 Loss, Lags Revenue Estimates

Trevena (TRVN) delivered earnings and revenue surprises of 11.11% and -84.42%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

TRVN : 0.5969 (+1.26%)
Trevena: Q3 Earnings Snapshot

CHESTERBROOK, Pa. (AP) _ Trevena Inc. (TRVN) on Monday reported a loss of $13.8 million in its third quarter.

TRVN : 0.5969 (+1.26%)
Trevena Reports Third Quarter 2021 Results

-- Advanced OLINVYK commercial launch with expanded field medical team and additional target markets Announced new OLINVYK cognitive function...

TRVN : 0.5969 (+1.26%)
Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team

Patricia Drake appointed new Chief Commercial Officer ...

TRVN : 0.5969 (+1.26%)
Trevena to Release Third Quarter 2021 Financial Results on November 15th, 2021

Company to host conference call on Monday, November 15th, 2021 at 8:00 a.m. ET...

TRVN : 0.5969 (+1.26%)
Earnings Preview: Trevena (TRVN) Q3 Earnings Expected to Decline

Trevena (TRVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TRVN : 0.5969 (+1.26%)
Trevena Announces Two OLINVYK® Presentations at ANESTHESIOLOGY® 2021

Posters highlight safety and tolerability data in two complex patient populations at higher risk for adverse events...

TRVN : 0.5969 (+1.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and developing therapeutics for G protein coupled receptors. The Company's product pipeline includes TRV027, TRV130, TRV734 and Delta opioid biased ligand which are in different clinical phases. Trevena, Inc. is based in King of...

See More

Key Turning Points

3rd Resistance Point 0.6571
2nd Resistance Point 0.6312
1st Resistance Point 0.6141
Last Price 0.5969
1st Support Level 0.5711
2nd Support Level 0.5452
3rd Support Level 0.5281

See More

52-Week High 3.1000
Fibonacci 61.8% 2.1297
Fibonacci 50% 1.8300
Fibonacci 38.2% 1.5303
Last Price 0.5969
52-Week Low 0.5600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar